AU3412600A - Peroxovanadium compounds as antineoplastic agents for the treatment of cancer - Google Patents

Peroxovanadium compounds as antineoplastic agents for the treatment of cancer

Info

Publication number
AU3412600A
AU3412600A AU34126/00A AU3412600A AU3412600A AU 3412600 A AU3412600 A AU 3412600A AU 34126/00 A AU34126/00 A AU 34126/00A AU 3412600 A AU3412600 A AU 3412600A AU 3412600 A AU3412600 A AU 3412600A
Authority
AU
Australia
Prior art keywords
cancer
treatment
antineoplastic agents
peroxovanadium compounds
peroxovanadium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34126/00A
Inventor
Victor A. Sandor
Paul James Scrivens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTRE FOR TRANSLATIONAL RESEARCH IN CANCER
Original Assignee
CT FOR TRANSLATIONAL RES IN CA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CT FOR TRANSLATIONAL RES IN CA filed Critical CT FOR TRANSLATIONAL RES IN CA
Publication of AU3412600A publication Critical patent/AU3412600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU34126/00A 1999-03-26 2000-03-23 Peroxovanadium compounds as antineoplastic agents for the treatment of cancer Abandoned AU3412600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12637699P 1999-03-26 1999-03-26
US60126376 1999-03-26
PCT/CA2000/000320 WO2000057860A2 (en) 1999-03-26 2000-03-23 Peroxovanadium compounds as antineoplastic agents for the treatment of cancer

Publications (1)

Publication Number Publication Date
AU3412600A true AU3412600A (en) 2000-10-16

Family

ID=22424504

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34126/00A Abandoned AU3412600A (en) 1999-03-26 2000-03-23 Peroxovanadium compounds as antineoplastic agents for the treatment of cancer

Country Status (4)

Country Link
EP (1) EP1165098A2 (en)
AU (1) AU3412600A (en)
CA (1) CA2365122A1 (en)
WO (1) WO2000057860A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2280249A1 (en) * 1999-08-12 2001-02-12 Universite Laval Vanadium compounds as anti-angiogenics and as inhibitors of endothelin production
WO2003031930A2 (en) 2001-10-09 2003-04-17 The Johns Hopkins University A phosphatase associated with metastasis
CA2386759A1 (en) * 2002-05-17 2003-11-17 Universite Laval Therapeutic uses of peroxometallic compounds
GB0328157D0 (en) * 2003-12-04 2004-01-07 Imp College Innovations Ltd Compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation

Also Published As

Publication number Publication date
CA2365122A1 (en) 2000-10-05
WO2000057860A3 (en) 2001-04-05
EP1165098A2 (en) 2002-01-02
WO2000057860A2 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
HUP0202807A3 (en) Compounds for the treatment of ischemia
IL174917A0 (en) Compounds useful as anti-inflammatory agents
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
AU2935200A (en) Compounds for the treatment of obesity
EP1176964B8 (en) Uses of et743 for treating cancer
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU2002217866A1 (en) Geldanamycin derivatives useful for the treatment of cancer
AU8322401A (en) Indole compounds useful for the treatment of cancer
HUP0402341A3 (en) Compositions containing thiazol-2-ylamines for the treatment of cancer
AU2001214116A1 (en) Novel paclitaxel derivatives for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU2021601A (en) Composition for the treatment of dandruff
IL134592A0 (en) Compositions comprising camptothecin compounds for the treatment of cancer with reduced side effects
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU3412600A (en) Peroxovanadium compounds as antineoplastic agents for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
HRP20020262A2 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
HK1043938A1 (en) Composition for the treatment of psoriasis
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2000263936A1 (en) Substance p analogs for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase